journal article·2024-11Open access

Augmenting osteoporotic bone regeneration through a hydrogel-based rejuvenating microenvironment

Xiaoting Zhang, Boguang Yang, Lu Feng, Xiayi Xu, Chenmin Wang, Yuk-wai Lee, Ming Wang, Xuan Lu, Ling Qin, Sien Lin, Liming Bian, Gang Li

Abstract

Osteoporotic bone defects pose a significant challenge for bone regeneration as they exhibit impaired healing capacity and delayed healing period. To address this issue, this study introduces a hydrogel that creates a rejuvenating microenvironment, thereby facilitating efficient bone repair during the initial two weeks following bone defect surgery. The hydrogel, named GelHFS, was created through host-guest polymerization of gelatin and acrylated β-cyclodextrin. Incorporation of the human fetal mesenchymal stem cell secretome (HFS) formed GelHFS hydrogel aimed at mimicking a rejuvenated stem cell niche. Our results demonstrated that GelHFS hydrogel promotes cell stellate spreading and osteogenic differentiation via integrin β1-induced focal adhesion pathway. Implantation of GelHFS hydrogel in an osteoporotic bone defect rat model recruited endogenous integrin β1-expressing cells and enhanced new bone formation and bone strength. Our findings reveal that GelHFS hydrogel provides a rejuvenating niche for endogenous MSCs and enhances bone regeneration in osteoporotic bone defect. These findings highlight the potential of GelHFS hydrogel as an effective therapeutic strategy for addressing challenging bone healing such as osteoporotic bone regeneration. • GelHFS hydrogel creates a rejuvenating microenvironment that promotes bone regeneration in an osteoporotic bone defect rat model. • GelHFS hydrogel undergoes degradation in accordance with bone remodeling process, driven by recruited endogenous cells. • GelHFS hydrogel promotes MSCs osteogenesis by activating the integrin β1 induced focal adhesion pathway.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Mesenchymal stem cell research · Extracellular vesicles in disease · MicroRNA in disease regulation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (47)

Show source-provided references
1. Fracture repair: general aspects and influence of osteoporosis and anti-osteoporosis treatment10.1016/S0020-1383(16)30003-1 ↗
2. Surgical treatment of osteoporotic fractures: an update on the principles of management10.1016/j.injury.2017.08.036 ↗
3. Failure of fracture fixation in osteoporotic bone10.1016/S0020-1383(16)47002-6 ↗
4. Bone repair in osteoporotic bone: postmenopausal and cortisone-induced osteoporosis10.1007/s00198-011-1612-3 ↗
5. Fracture healing in osteoporotic bone10.1016/S0020-1383(16)47004-X ↗
6. Advancing application of mesenchymal stem cell-based bone tissue regeneration
7. Senescence in human mesenchymal stem cells: functional changes and implications in stem cell-based therapy10.3390/ijms17071164 ↗
8. Manufacturing mesenchymal stromal cells for clinical applications: a survey of Good Manufacturing Practices at U.S. academic centers10.1016/j.jcyt.2019.04.003 ↗
9. Challenges and controversies in human mesenchymal stem cell therapy
10. Regenerative cell-based therapies: cutting edge, bleeding edge, and off the edge10.1007/s40883-020-00147-1 ↗
11. Stem cell therapy without the cells10.4161/cib.26631 ↗
12. The Life and fate of mesenchymal stem cells10.3389/fimmu.2014.00148 ↗
13. The immunomodulatory functions of mesenchymal stromal/stem cells mediated via paracrine activity10.3390/jcm8071025 ↗
14. Chapter 13 - stem cells and regenerative medicine
15. Mesenchymal stromal cell apoptosis is required for their therapeutic function10.1038/s41467-021-26834-3 ↗
16. Secretome of human fetal mesenchymal stem cell ameliorates replicative senescen10.1089/scd.2016.0079 ↗
17. Human fetal mesenchymal stem cell secretome enhances bone consolidation in distraction osteogenesis10.1186/s13287-016-0392-2 ↗
18. Human fetal mesenchymal stem cells secretome promotes scarless diabetic wound healing through heat‐shock protein family
19. Injectable stem cell-laden supramolecular hydrogels enhance in situ osteochondral regeneration via the sustained co-delivery of hydrophilic and hydrophobic chondrogenic molecules10.1016/j.biomaterials.2019.04.031 ↗
20. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration10.1016/j.biomaterials.2009.01.031 ↗
21. Dynamic and cell-infiltratable hydrogels as injectable carrier of therapeutic cells and drugs for treating challenging bone defects10.1021/acscentsci.8b00764 ↗
22. Dynamic gelatin-based hydrogels promote the proliferation and self-renewal of embryonic stem cells in long-term 3D culture10.1016/j.biomaterials.2022.121802 ↗
23. Mechanically resilient, injectable, and bioadhesive supramolecular gelatin hydrogels crosslinked by weak host-guest interactions assist cell infiltration and in situ tissue regeneration10.1016/j.biomaterials.2016.05.043 ↗
24. Immortalized human fetal bone marrow-derived mesenchymal stromal cell expressing suicide gene for anti-tumor therapy in vitro and in vivo10.1016/j.jcyt.2013.06.010 ↗
25. Enhanced mechanosensing of cells in synthetic 3D matrix with controlled biophysical dynamics10.1038/s41467-021-23120-0 ↗
26. Bioactive scaffold fabricated by 3D printing for enhancing osteoporotic bone regeneration10.3390/bioengineering9100525 ↗
27. KAAS: an automatic genome annotation and pathway reconstruction server10.1093/nar/gkm321 ↗
28. A novel pulsed electromagnetic field promotes distraction osteogenesis via enhancing osteogenesis and angiogenesis in a rat model10.1016/j.jot.2020.10.007 ↗
29. Biodegradable magnesium combined with distraction osteogenesis synergistically stimulates bone tissue regeneration via CGRP-FAK-VEGF signaling axis
30. A metaphyseal fracture rat model for mechanistic studies of osteoporotic bone healing10.22203/eCM.v037a25 ↗
31. The mechanical properties and cytotoxicity of cell-laden double-network hydrogels based on photocrosslinkable gelatin and gellan gum biomacromolecules10.1016/j.biomaterials.2011.12.050 ↗
32. Molecular mechanisms responsible for therapeutic potential of mesenchymal stem cell-derived secretome10.3390/cells8050467 ↗
33. Insights into the secretome of mesenchymal stem cells and its potential applications10.3390/ijms20184597 ↗
34. The role of secreted factors in stem cells-mediated immune regulation10.1016/j.cellimm.2017.07.010 ↗
35. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles10.3402/jev.v3.26913 ↗
36. Exosomes and extracellular vesicles: the path forward10.1042/EBC20170088 ↗
37. Mesenchymal stromal cell secretome: influencing therapeutic potential by cellular pre-conditioning10.3389/fimmu.2018.02837 ↗
38. The therapeutic effect of secretome from human umbilical cord-derived mesenchymal stem cells in age-related osteoporosis10.1080/21691401.2019.1596945 ↗
39. Capturing magnesium ions via microfluidic hydrogel microspheres for promoting cancellous bone regeneration10.1021/acsnano.1c02147 ↗
40. Synergistic anti-inflammatory and osteogenic n-HA/resveratrol/chitosan composite microspheres for osteoporotic bone regeneration
41. Rehabilitation exercise–driven symbiotic electrical stimulation system accelerating bone regeneration10.1126/sciadv.adi6799 ↗
42. Integrin-mediated interactions between human bone marrow stromal precursor cells and the extracellular matrix10.1016/S8756-3282(00)00424-5 ↗
43. Erk is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells10.1074/jbc.M010021200 ↗
44. Interactions between extracellular signal-regulated kinase 1/2 and P38 Map kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity10.1002/jbmr.561 ↗
45. Activation of FAK is necessary for the osteogenic differentiation of human mesenchymal stem cells on laminin-510.1002/jcb.21074 ↗
46. Matrix metalloproteinases in bone resorption, remodeling, and repair10.1016/bs.pmbts.2017.05.001 ↗